News

  • uMotif expands leadership team to support growth in US and EU markets

    Read More
  • uMotif and ClinOne Unify eCOA / ePRO and eConsent to Improve the Participant Experience and Endpoint Data Quality in Global Clinical Trials

    Read More
  • $25.5m of new investment from a fund managed by Athyrium Capital Management

    Read More
  • Achieving More Meaningful Patient Engagement in Rare Disease Trials

    Read More
  • AbbVie and uMotif support Rheumatoid Arthritis patients with Bring Your Own Device approach to capturing study data

    Read More
  • uMotif collaborates with The University of Manchester on body mapping tool

    Read More
  • uMotif evolves leadership team with appointment of Steve Rosenberg as CEO

    Read More
  • uMotif Adds eClinical Industry Veteran Steve Rosenberg to Board of Directors

    Read More
  • uMotif and VirTrial partner to further expand decentralized clinical trial capabilities

    Read More